Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01792986 · ClinicalTrials.gov registry record · NA
The Fasting II Study
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01792986 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 12 participants.
The verdict
NCT01792986, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will determine whether an intensive fasting protocol alters hemoglobin A1c measurements or other markers of metabolic and cardiovascular risk by performing a 5-week clinical trial of fasting among 12 pre-diabetic individuals or diabetics whose disease is controlled by diet. Participants will undergo a 5-week intervention of once-per-week 24-hour water-only fasting, including at baseline and at the end of the week for each week of the study (a total of 6 24-hour fasts).
Interventions
- BEHAVIORAL water-only 24-hour fasting once per week for 6 weeks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01792986
The ClinicalTrials.gov registry entry for NCT01792986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which water-only 24-hour fasting once per week for 6 weeks is the first listed.
NCT01792986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01792986 about?
NCT01792986 is a clinical study titled "The Fasting II Study". This study will determine whether an intensive fasting protocol alters hemoglobin A1c measurements or other markers of metabolic and cardiovascular risk by performing a 5-week clinical trial of fasting among 12 pre-diabetic individuals or diabetics whose disease is controlled by diet. Participants w...
What is the current status of trial NCT01792986?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-02. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01792986?
The interventions under investigation include: water-only 24-hour fasting once per week for 6 weeks (BEHAVIORAL).
Who is sponsoring clinical trial NCT01792986?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.